Blood Screening Market size was valued at USD 2.44 billion in 2020 and is projected to reach USD 4.83 billion by 2029, growing at a CAGR of 7.9% from 2022.
Cancer Biomarkers & Pharmaceutical Companies Lining Up for Clinical Trials to Cater to Growing Demand, Pushing Sales Past US$ 11 Billion in 2022 In its latest.
Cancer Biomarkers & Pharmaceutical Companies Lining Up for Clinical Trials to Cater to Growing Demand, Pushing Sales Past US$ 11 Billion in 2022 In its latest report, Fact.MR presents an
NEW YORK, Aug. 11, 2022 /PRNewswire/ According to a Comprehensive Research Report by Data Bridge Market Research on Global Cancer Diagnostics Market research report is an expert's analysis